40% of all cardiology clinical trials do not focus on the most at risk population, elderly patients.
Despite older age being a well-established factor associated with cardiovascular risk, the needs of this population remains underserved in product development for clinical trials.
The shift of clinical trials to a decentralized setting, not only digital, is crucial in collecting data from at risk patients by providing them accessibility to continuous data collection tools from the comfort of their own home.
| Technical possibilities
